Helix BioPharma Corp.

Helix BioPharma Corp.verified

HBPCF

Price:

$1.71

Market Cap:

$120.68M

Helix BioPharma Corp. is a Canadian enterprise focused on immuno-oncology. The company's research and development efforts include L-DOS47, a drug candidate aimed at treating non-small cell lung cancer, and V-DOS47, which is designed to interact with vascular epithelial growth factor receptor 2 (VEGFR2). Helix has established collaborative agreements to further its research. One such partnership with Moffitt Cancer Center involves studying L-DOS47's pharmacodynamics and exploring the advantages of co-administering it with immune checkpoint inhibitors. A separate collaboration with University Hospital Tuebingen focuses on evaluating L-DOS47's therapeutic impact on CEACAM6-positive cancer model...[Read more]

Industry

Biotechnology

IPO Date

2009-11-27

Stock Exchange

OTC

Ticker

HBPCF

The ROE as of June 2026 (TTM) for Helix BioPharma Corp. (HBPCF) is -21.54%

According to Helix BioPharma Corp.’s latest financial reports and current stock price. The company's current ROE is -21.54%. This represents a change of 301.62% compared to the average of -5.36% of the last 4 quarters.

Helix BioPharma Corp. (HBPCF) Historical ROE (quarterly & annually)

How has HBPCF ROE performed in the past?

The mean historical ROE of Helix BioPharma Corp. over the last ten years is 6.90%. The current -21.54% ROE has changed -100.31% with respect to the historical average. Over the past ten years (40 quarters), HBPCF's ROE was at its highest in in the July 2017 quarter at 7.33%. The ROE was at its lowest in in the October 2019 quarter at -4962.22%.

Quarterly (TTM)
Annual

Average

6.90%

Median

398.07%

Minimum

-1905.96%

Maximum

59.25%

Helix BioPharma Corp. (HBPCF) ROE by Quarter and Year

Discovering the peaks and valleys of Helix BioPharma Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.28%

Maximum Annual ROE = 59.25%

Minimum Annual Increase = -19463.39%

Minimum Annual ROE = -1905.96%

Quarterly (TTM)
Annual
YearROEChange
2025-33.40%-100.32%
202410.29%1.28%
2023745.26%-139.10%
2022-1905.96%-435.61%
2021567.91%-250.90%
2020-376.36%-264.05%
2019229.41%-59.52%
2018566.73%-99.04%
201759.25%-19463.39%
2016-306.01%138.95%

Helix BioPharma Corp. (HBPCF) Average ROE

How has HBPCF ROE performed in the past?

The current ROE of Helix BioPharma Corp. (HBPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.67%

5-year avg

1.93%

10-year avg

6.90%

Helix BioPharma Corp. (HBPCF) ROE vs. Peers

How is HBPCF’s ROE compared to its peers?

Helix BioPharma Corp.’s ROE is less than MindMaze Therapeutics Holding S.A. Sponsored ADR (0%), greater than Calliditas Therapeutics Ab (-84.68%), greater than PsyBio Therapeutics Corp. (-867.29%), less than MindMaze Therapeutics Holding S.A. (0%), less than Arch Biopartners Inc. (70.15%), greater than Amplia Therapeutics Limited (-18.71%), less than ZIVO Bioscience, Inc. (353.53%), greater than TransCanna Holdings Inc. (-239.59%), less than Oncotelic Therapeutics, Inc. (0.00%), less than Vicapsys Life Sciences, Inc. (14.08%),

Build a custom stock screener for Helix BioPharma Corp. (HBPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Helix BioPharma Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Helix BioPharma Corp. (HBPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Helix BioPharma Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Helix BioPharma Corp.'s ROE?

How is the ROE calculated for Helix BioPharma Corp. (HBPCF)?

What is the highest ROE for Helix BioPharma Corp. (HBPCF)?

What is the 3-year average ROE for Helix BioPharma Corp. (HBPCF)?

What is the 5-year average ROE for Helix BioPharma Corp. (HBPCF)?

How does the current ROE for Helix BioPharma Corp. (HBPCF) compare to its historical average?